Use of methadone in the treatment of psychotic patients with comorbid opioid dependence;Bruk av metadon i behandlingen av heroinavhengige psykotiske pasienter

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 2, 2000, Pages 195-198

  Walby, Fredrik A ^a,e   Borg, Per ^a   Eikeseth, Per Håkon ^b   Neegaard, Elsa ^b,f   Kjerpeseth, Knut ^c   Bruvik, Steinar ^d,g   Waal, Helge ^d  

^a Kirurgisk avdeling Diakonhjemmets sykehus   (Norway)

^b Vor Frues Hospital   (Norway)

^c Nordland Psykiatriske Sykehus   (Norway)

^d Senter Metadonassistert R   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f Barne Ungdomspsykiatrisk P   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; HUMAN; NEUROBIOLOGY; NORWAY; OPIATE ADDICTION; PATIENT COMPLIANCE; PSYCHOSIS; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; PSYCHOTIC DISORDERS;

EID: 0034688201     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589-608.
2. Dole VP, Nyswander ME. A medical treatment for diacetyl-morphine (heroin) addiction. JAMA 1965; 193: 646.
3. Waal H, Blix O, Krook A, Olsen H. Bruk av metadon i behandlingen av opioidavhengighet. Tidsskr Nor Lægeforen 1999; 119: 237-41.
4. Blix O, Bruvik S, Waal H. Metadonprosjektet i Oslo. Tidsskr Nor Lægeforen 1999; 119: 242-6.
5. Brizer DA, Hartman N, Sweenwy J, Millman RB. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia. Am J Psychiatry 1985; 142: 1106-7.
6. Feinberg DT, Hartmann N. Methadone and schizophrenia. Am J Psychiatry 1991; 148: 12.
7. Judd LL, Janowsky DS, Segal DS, Parker DC, Huey LY. Behavioral effects of methadone in schizophrenic patients. Am J Psychiatry 1981; 138: 243-5.
8. Goldstein A. Addiction - from biology to drug policy. New York: Freeman, 1994.
9. Øye I. Farmakologiske prinsipper for behandling av heroinmisbruk. Tidsskr Nor Lægeforen 1999; 119: 2066-9.
10. Koob GF. Drugs of abuse: anatomy, pharmacology and functions of the reward pathways. Trends Pharmacol Sci 1992; 13: 177-84.
11. Gardner EL. Brain reward mechanisms. I: Lowinson JH, Ruitz P, Millman RB, Langrod JG, red. Substance abuse. A comprehensive textbook. Baltimore: Williams & Wilkins, 1997: 51-84.
12. Simon EJ. Opiates: neurobiology. I: Lowinson JH, Ruitz P, Millman RB, Langrod JG, red. Substance abuse. A comprehensive textbook. Baltimore: Williams & Wilkins, 1997: 148-57.
13. Midlertidige retningslinjer for metadonassistert rehabilitering. Rundskriv 1-25/98. Oslo: Sosial- og helsedepartementet, 1998.